John Bial

Chief Executive Officer at Capsigen, Inc.

Health Technology

Profile

John Bial is currently the Chief Executive Officer at Capsigen, Inc. since 2020.
Prior to this, he worked at Yecuris Corp.
as the President, Chief Executive Officer & Director.

John Bial active positions

Companies	Position	Start
Capsigen, Inc. Capsigen, Inc. BiotechnologyHealth Technology Capsigen, Inc. is a company based in Vancouver, WA that is developing the next generation of AAV vectors for gene therapy. The company's end-to-end platform uses customized, diverse libraries and proprietary trade™ technology to identify fully functional vectors that meet disease-specific transduction criteria. Capsigen's fit-for-purpose vectors are designed to deliver the highest level of clinical utility in a rapid and high-throughput manner. The company uses data science and directed evolution to build custom AAV capsids to move patients from hope to cured. John Bial has been the CEO of the company since 2020.	Chief Executive Officer	2020-02-29

All active positions of John Bial

Former positions of John Bial

Companies	Position	End
Yecuris Corp. Yecuris Corp. BiotechnologyHealth Technology Yecuris Corp. offers drug discovery and development services for liver toxicity. Its products and services include In Vitro, In Vivo, Reagents, and Application Data. The company was founded by Markus Grompe in 2007 and is headquartered in Portland, OR.	Chief Executive Officer	-

See the detail of John Bial's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Bial's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Yecuris Corp. Yecuris Corp. BiotechnologyHealth Technology Yecuris Corp. offers drug discovery and development services for liver toxicity. Its products and services include In Vitro, In Vivo, Reagents, and Application Data. The company was founded by Markus Grompe in 2007 and is headquartered in Portland, OR.	Health Technology
Capsigen, Inc. Capsigen, Inc. BiotechnologyHealth Technology Capsigen, Inc. is a company based in Vancouver, WA that is developing the next generation of AAV vectors for gene therapy. The company's end-to-end platform uses customized, diverse libraries and proprietary trade™ technology to identify fully functional vectors that meet disease-specific transduction criteria. Capsigen's fit-for-purpose vectors are designed to deliver the highest level of clinical utility in a rapid and high-throughput manner. The company uses data science and directed evolution to build custom AAV capsids to move patients from hope to cured. John Bial has been the CEO of the company since 2020.	Health Technology